Europe IT Spending on Business Intelligence to 2012 Pharmaceutical Technology

Table of Contents

• OVERVIEW
  • CATALYST
  • SUMMARY
  • METHODOLOGY
• EUROPE IT SPENDING ON BUSINESS INTELLIGENCE SOLUTIONS IN PHARMA
  • Introduction
  • Spending by the US and Europe pharmaceutical industry on BI to 2012
  • Spending by the Big Pharma in Europe on BI to 2012
  • Spending on BI solutions by US pharmaceutical sub-segments to 2012
  • Spending by US Big Pharma on BI solutions by technology to 2012
  • Spending by Global Big Pharma on BI solutions by end-user group to 2012
  • Spending by Global Biotech on BI solutions by end-user group to 2012
• APPENDIX
  • Definitions
  • Further reading
  • Ask the analyst
  • Datamonitor consulting
  • List of Tables
    • Table 1: Spending by US and Europe pharmaceutical industry on BI solutions to 2012
    • Table 2: Spending by the Big Pharma in Europe on BI to 2012
    • Table 3: Spending on BI solutions by Big Pharma in the UK, France, Switzerland and Germany to 2012
    • Table 4: Spending by Big Pharma in Europe on BI solutions by technology
    • Table 5: Spending by Big Pharma on BI solutions by end-user group to 2012 (US & Europe)
    • Table 6: Spending by Biotech on BI solutions by end-user group to 2012 (US)
  • List of Figures
    • Figure 1: Spending by US and Europe pharmaceutical industry on BI solutions to 2012
    • Figure 2: Spending by the Big Pharma in Europe on BI to 2012
    • Figure 3: Spending on BI solutions by Big Pharma in the UK, France, Switzerland and Germany to 2012
    • Figure 4: Spending by Big Pharma in Europe on BI solutions by technology
    • Figure 5: Spending by Big Pharma on BI solutions by end-user group to 2012 (US & Europe)
    • Figure 6: Spending by Biotech on BI solutions by end-user group to 2012 (US)